|
Screening
|
Who needs it
|
How often
|
|
Alcohol misuse
|
All adults
|
At routine exams
|
|
Blood pressure
|
All adults
|
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommends the following screening schedules:
Every 2 years - blood pressure reading < 120/80 mm Hg, and
Yearly - systolic blood pressure reading of 120 to 139 mm Hg or diastolic blood pressure of 80 to 89 mm Hg
|
|
Breast cancer
|
All women
|
Yearly mammogram and clinical breast exam*
|
|
Cervical cancer
|
An update to this recommendation is currently in progress and being reviewed by the USPSTF. The recommendation below may contain information that is out of date. Please consult your healthcare provider.
Women who have been sexually active and have a cervix
|
Please discuss with your healthcare provider.
The American Cancer Society (ACS) recommends a pap test every 2 years.
The American Congress of Obstetricians and Gynecologists (ACOG) currently recommends that women ages 30 and older get a pap tests once every 3 years, and women with certain risk factors (or at increased risk) may need more frequent screening.**
|
|
Chlamydia
|
Women at increased risk for infection
|
At routine exams
|
|
Colorectal cancer
|
All adults
|
Check with your healthcare provider
Fecal occult blood testing, sigmoidoscopy, or colonoscopy is recommended as screening methods.
|
|
Depression
|
All adults in clinical practices that have staff and systems in place to assure accurate diagnosis, effective treatment, and follow-up
|
At routine exams
|
|
Diabetes Mellitus, type 2
|
Adults who are asymptomatic with sustained blood pressure (either treated or untreated) greater than 135/80 mm Hg
|
At routine exams
|
|
Gonorrhea
|
Sexually active women at increased risk for infection
|
At routine exams
|
| HIV |
Anyone at increased risk for infection |
At routine exams |
| Lipid Disorders |
All women age 45 and older at increased risk for coronary artery disease |
At least every five years |
|
Obesity
|
All adults |
At routine exams
|
| Osteoporosis, Postmenopausal Women |
An update to this recommendation is currently in progress and being reviewed by the USPSTF. The recommendation below may contain information that is out of date. Please discuss with your healthcare provider.
Women at age 60 who are at increased risk for osteoporotic fractures
|
Please consult your healthcare provider |
|
Syphilis
|
Anyone at increased risk for infection
|
At routine exams
|
|
Tuberculosis
|
Anyone at increased risk for infection
|
Check with your healthcare provider
|
|
Counseling
|
Who needs it
|
How often
|
|
Aspirin for prevention of cardiovascular events
|
At-risk adults
Recommended for women age 55 to 79 years when the potential benefit of a reduction in ischemic strokes outweighs the potential harm of an increase in gastrointestinal hemorrhage.
|
When risk is identified, and please discuss with your healthcare provider
|
| Breast cancer, chemoprevention |
An update to this recommendation is currently in progress and being reviewed by the USPSTF. The recommendation below may contain information that is out of date. Please discuss with your healthcare provider.
Women with high risk
|
The recommendation below may contain information that is out of date. Please consult your healthcare provider.
When risk is identified
|
| BRCA mutation testing for breast and ovarian cancer susceptibility |
Women with increased risk |
When risk is identified |
|
Diet, behavioral counseling
|
Adults with hyperlipidemia and other known risk factors for cardiovascular and diet-related chronic disease
|
When diagnosed
|
|
Tobacco use and Tobacco-Caused Disease
|
All adults
|
Every visit
|
|
Immunization
|
Who needs it
|
How often
|
|
Tetanus/diphtheria/pertussis (Td/Tdap) booster
|
All adults
|
Td: Every 10 years
Tdap: Substitute a one-time dose of Tdap for a Td booster - Once after age 18
|
|
Measles, mumps, rubella (MMR)
|
All adults age 50 to 64 who lack prior infection or documented vaccinations***
|
One dose
|
|
Chickenpox (varicella)
|
Adults age 50 to 64 and who lack prior infection or documented vaccinations***
|
Two doses. The second dose should be administered 4 to 8 weeks after the first dose.
|
|
Flu vaccine (seasonal)
|
All adults
|
Yearly during flu season
|
|
Hepatitis A vaccine
|
People at risk***
|
Two doses
Schedule:
Zero and 6 to 12 months (Havrix), OR
Zero and 6 to 18 months schedule (Vaqta)
|
|
Hepatitis B vaccine
|
People at risk***
|
Three doses over six months
Second dose should be administered 1 month after the first dose; the third dose should be administered at least 2 months after the second dose (and at least 4 months after the first dose)
|
|
Meningococcal
|
People at risk***
|
One or more doses
|
|
Pneumococcal (polysaccharide)
|
People at risk***
|
One or two doses
|
|
Zoster
|
All women age 60 and older***
|
One dose
|